Clinical Trials Browser

Phase 1/2 × indibulin × Breast × Clear all

NCT01113970 2013-01-30

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms